|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 110, Issue 9 1123-1132, Copyright © 1997 by Company of Biologists
JOURNAL ARTICLES |
M Perrot-Applanat, O Gualillo, H Buteau, M Edery and PA Kelly
INSERM U 344, Faculte de Medecine Necker-Enfants Malades, Paris, France.
Prolactin (PRL) interacts with a specific, well characterized plasma membrane receptor (PRLR) that is coupled to signal transduction pathways involving Jak2, Fyn, and MAP kinases, and signal transducers and activators of transcription (STAT). Although a few previous studies have indicated nuclear translocation of PRL in IL-2 stimulated T lymphocytes, PRL-dependent Nb2 lymphoma cell lines and 235-1 lactotrophs, the mechanisms of nuclear targeting remain unknown and conflicting results have been reported concerning the putative nuclear translocation of the PRLR. We therefore decided to investigate nuclear translocation of PRLR and PRL in various cell lines transfected with an expression plasmid encoding PRLR, using confocal laser microscopy. We have constructed various cDNAs of the long and short forms of the rat PRLR containing an oligonucleotide encoding a Flag epitope inserted either just before the N-terminal amino acid or in the C-terminal end of the mature receptor (named N-terminal or C-terminal Flag-tagged PRLR). The corresponding receptors function as the PRLR in transfected cells: they are expressed at the plasma membrane and in compartments of the secretory pathway, they bind PRL with normal affinity (Kd= 4x10(-10) M) and have the same capacity to stimulate the transcriptional activity of a milk protein (beta-casein) gene as wild-type PRLR. In addition, the tagged receptors are much more efficiently immunodetected using anti-Flag antibodies, as compared to anti-PRL antibodies (U5 or U6). Immunofluorescence combined with detailed confocal laser microscopy showed that addition of PRL (0 to 12 hours) to COS-7, CHO and NIH-3T3 transfected fibroblasts induces rapid internalization of the receptor (long form), without any translocation to the nucleus. Using PRL-R tagged both in the N-terminal or C-terminal regions of the mature receptor excludes the possibility of a cleaved fragment which could have been subsequently imported into the nucleus. An absence of nuclear translocation of PRLR was also observed in a 293 cell line stably expressing the receptor, and in physiological targets for PRL, i.e. in Nb2 lymphoma cells expressing the Nb2 form of the receptor or in BGME mammary gland epithelial cells upon overexpression of a Flag-tagged PRLR. Similarly, the short form of the PRLR was not detected in nuclei of transfected COS cells upon PRL treatment. Clearly, our results provide evidence that internalization of the plasma membrane PRLR does not lead to nuclear translocation of the receptor, or part of it, in most fibroblasts and epithelial cells at physiological concentrations of PRL. Also, in co-localization experiments, PRL was internalized without nuclear translocation. Activation of STATs transcription factors and MAP kinases, as well as translocation of these proteins to the nucleus following their phosphorylation, probably remains the intracellular mechanism coupling stimulation to nuclear events.
This article has been cited by other articles:
|
|
 |
|
  N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans? Endocr. Rev., February 1, 2008; 29(1): 1 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Piwnica, I. Fernandez, N. Binart, P. Touraine, P. A. Kelly, and V. Goffin A New Mechanism for Prolactin Processing into 16K PRL by Secreted Cathepsin D Mol. Endocrinol., December 1, 2006; 20(12): 3263 - 3278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Lu, T. M. Piazza, and L. A. Schuler Proteasomes Mediate Prolactin-induced Receptor Down-regulation and Fragment Generation in Breast Cancer Cells J. Biol. Chem., October 7, 2005; 280(40): 33909 - 33916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Hou, S. Srivastava, M. J. Mistry, M. P. Herbst, J. P. Bailey, and N. D. Horseman Two Tandemly Linked Interferon-{gamma}-Activated Sequence Elements in the Promoter of Glycosylation-Dependent Cell Adhesion Molecule 1 Gene Synergistically Respond to Prolactin in Mouse Mammary Epithelial Cells Mol. Endocrinol., October 1, 2003; 17(10): 1910 - 1920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Saunier, F. Dif, P. A. Kelly, and M. Edery Targeted Expression of the Dominant-Negative Prolactin Receptor in the Mammary Gland of Transgenic Mice Results in Impaired Lactation Endocrinology, June 1, 2003; 144(6): 2669 - 2675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Binart, P. Imbert-Bollore, N. Baran, C. Viglietta, and P. A. Kelly A Short Form of the Prolactin (PRL) Receptor Is Able to Rescue Mammopoiesis in Heterozygous PRL Receptor Mice Mol. Endocrinol., June 1, 2003; 17(6): 1066 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Olsnes, O. Klingenberg, and A. Wiedlocha Transport of Exogenous Growth Factors and Cytokines to the Cytosol and to the Nucleus Physiol Rev, January 1, 2003; 83(1): 163 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Lu, P. Scott, G. J. Strous, and L. A. Schuler Multiple Internalization Motifs Differentially Used by Prolactin Receptor Isoforms Mediate Similar Endocytic Pathways Mol. Endocrinol., November 1, 2002; 16(11): 2515 - 2527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ben-Jonathan and R. Hnasko Dopamine as a Prolactin (PRL) Inhibitor Endocr. Rev., December 1, 2001; 22(6): 724 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Glasow, L.-C. Horn, S. E. Taymans, C. A. Stratakis, P. A. Kelly, U. Kohler, J. Gillespie, B. K. Vonderhaar, and S. R. Bornstein Mutational Analysis of the PRL Receptor Gene in Human Breast Tumors with Differential PRL Receptor Protein Expression J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3826 - 3832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Rycyzyn, S. C. Reilly, K. O’Malley, and C. V. Clevenger Role of Cyclophilin B in Prolactin Signal Transduction and Nuclear Retrotranslocation Mol. Endocrinol., August 1, 2000; 14(8): 1175 - 1186. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. RYCYZYN and C. V. CLEVENGER Role of Cyclophilins in Somatolactogenic Action Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 514 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Vleurick, A. Pezet, E. R. Kühn, E. Decuypere, and M. Edery A {beta}-Turn Endocytic Code Is Required for Optimal Internalization of the Growth Hormone Receptor but Not for {alpha}-Adaptin Association Mol. Endocrinol., November 1, 1999; 13(11): 1823 - 1831. [Abstract] [Full Text]
|
|
|
|
|
|
H. Buteau, A. Pezet, F. Ferrag, M. Perrot-Applanat, P. A. Kelly, and M. Edery N-Glycosylation of the Prolactin Receptor Is Not Required for Activation of Gene Transcription but Is Crucial for Its Cell Surface Targeting Mol. Endocrinol., April 1, 1998; 12(4): 544 - 555. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. Berlanga, J. P. Garcia-Ruiz, M. Perrot-Applanat, P. A. Kelly, and M. Edery The Short Form of The Prolactin (PRL) Receptor Silences PRL Induction of the {beta}-Casein Gene Promoter Mol. Endocrinol., September 1, 1997; 11(10): 1449 - 1457. [Abstract] [Full Text]
|
|
